clia
Latest
Theranos settlement means it could have a lab again in 2019
Theranos has been headed toward disaster for a while through its questonable blood testing methods, but it might have just avoided the worst possible outcome. The biotech outfit has reached a settlement with the Centers for Medicare & Medicaid Services that should end the legal and regulatory fights between the two. In return for Theranos dropping appeals of both its 2-year lab ban and sanctions on its Newark lab, CMS has decided against revoking Theranos' Clinical Laboratory Improvement Amendments (CLIA) certificates and reducing the civil financial penalty to $30,000. Theranos is voluntarily giving up the certificates, as it's not running labs that would need them.
Theranos CEO Elizabeth Holmes banned from owning a lab
Spoiler warning in case you don't want to know how the movie will probably end: the Wall Street Journal reports US regulators have devised to ban the owners and operators of Theranos from running a lab for two years. That includes CEO & founder Elizabeth Holmes, as confirmed by a press release issued tonight. The Centers for Medicare & Medicaid Services (CMS) revoked the lab's Clinical Laboratory Improvement Amendments (CLIA) certificate and imposed a civil money penalty for an unspecified amount.
